| 1 |
Tamoxifen-resistant breast cancer cell line ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 Breast Tumor ... |
| Perturbation |
Tamoxifen |
| Disease |
Breast Cancer |
|
| 2 |
Tamoxifen-resistant breast cancer cell line ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 Breast Tumor ... |
| Perturbation |
Tamoxifen |
| Disease |
Breast Cancer |
|
| 3 |
Tamoxifen-resistant breast cancer cell line ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 Breast Tumor ... |
| Perturbation |
Tamoxifen |
| Disease |
Breast Cancer |
|
| 4 |
Estrogen receptor alpha/beta heterodimer ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
U2OS Osteosarcoma |
| Perturbation |
Tamoxifen (Estrogen ... |
| Disease |
Osteosarcoma |
|
| 5 |
Estrogen receptor alpha/beta heterodimer ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
U2OS Osteosarcoma |
| Perturbation |
Tamoxifen (Estrogen ... |
| Disease |
Osteosarcoma |
|
| 6 |
Estrogen receptor alpha/beta heterodimer ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
U2OS Osteosarcoma |
| Perturbation |
Tamoxifen (Estrogen ... |
| Disease |
Osteosarcoma |
|
| 7 |
Transgenic model of selective ATF6 activation: ...
|
Mus musculus
|
Mus musculus |
| Cell |
Cardiac (Mus ... |
| Perturbation |
Tamoxifen |
| Disease |
Impaired Endoplasmic ... |
|
| 8 |
Transgenic model of selective ATF6 activation: ...
|
Mus musculus
|
Mus musculus |
| Cell |
Cardiac (Mus ... |
| Perturbation |
Tamoxifen |
| Disease |
Impaired Endoplasmic ... |
|
| 9 |
Tamoxifen-resistant breast cancer cell line ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 Breast Cancer ... |
| Perturbation |
Tamoxifen |
| Disease |
Breast Cancer |
|
| 10 |
Tamoxifen-resistant breast cancer cell line ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 Breast Cancer ... |
| Perturbation |
Tamoxifen |
| Disease |
Breast Cancer |
|
| 11 |
Proteasome inhibitor Bortezomib effect on MCF7 ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 Breast Cancer |
| Perturbation |
Bortezomib |
| Disease |
Breast Cancer |
|
| 12 |
Transgenic model of selective ATF6 activation: ...
|
Mus musculus
|
Mus musculus |
| Cell |
Cardiac ATF6MER ... |
| Perturbation |
Tamoxifen |
| Disease |
Endoplasmic Reticulum ... |
|
| 13 |
Transgenic model of selective ATF6 activation: ...
|
Mus musculus
|
Mus musculus |
| Cell |
Cardiac ATF6MER ... |
| Perturbation |
Tamoxifen |
| Disease |
Endoplasmic Reticulum ... |
|
| 14 |
Effect of estrogen receptor- or retinoic acid ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 Breast Cancer Cell |
| Perturbation |
Estrogen depletion ... |
| Disease |
Breast Cancer |
|
| 15 |
Effect of estrogen receptor- or retinoic acid ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 Breast Cancer Cell |
| Perturbation |
Retinoic acid ... |
| Disease |
Breast Cancer |
|
| 16 |
Effect of estrogen receptor- or retinoic acid ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 Breast Cancer Cell |
| Perturbation |
Estrogen receptor ... |
| Disease |
Breast Cancer |
|
| 17 |
Effect of estrogen receptor- or retinoic acid ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 Breast Cancer Cell |
| Perturbation |
Estrogen receptor ... |
| Disease |
Breast Cancer |
|
| 18 |
Effect of estrogen receptor- or retinoic acid ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 Breast Cancer Cell |
| Perturbation |
Retinoic acid ... |
| Disease |
Breast Cancer |
|
| 19 |
Effect of estrogen receptor- or retinoic acid ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 Breast Cancer Cell |
| Perturbation |
Retinoic acid ... |
| Disease |
Breast Cancer |
|
| 20 |
Embryonic stem cell response to STAT3 ...
|
Mus musculus
|
Mus musculus |
| Gene |
STAT3 |
| Cell |
Embryonic Stem Cell |
| Perturbation |
Gene Overexpression |
| Disease |
Pluripotency Maintainence |
|
| 21 |
Expression data from PKM1 or PKM2 expressing ...
|
Mus musculus
|
Mus musculus |
| Gene |
PKM2 |
| Cell |
Mouse Embryonic ... |
| Perturbation |
Deletion; Tamoxifen |
| Disease |
Global Gene Expression |
|
| 22 |
Gene expression data from type II pneumocytes ...
|
Mus musculus
|
Mus musculus |
| Gene |
TERF2 |
| Cell |
Alveolar Epithelial ... |
| Perturbation |
Deletion |
| Disease |
Degenerative Disease |
|
| 23 |
HOXB7 is an ERα cofactor in the activation of ...
|
Homo sapiens
|
Homo sapiens |
| Gene |
ERBB2 |
| Cell |
MCF7 Breast Cancer |
| Perturbation |
Overexpression of HOXB7 |
| Disease |
Breast Cancer |
|
| 24 |
Knock out of NOTCH1-bound MYC enhancer (N-Me)
|
Mus musculus
|
Mus musculus |
| Gene |
NOTCH1 |
| Cell |
Lymphoblastic ... |
| Perturbation |
Knockout |
| Disease |
Cancer |
|
| 25 |
MicroRNAs control the apoptotic threshold in ...
|
Mus musculus
|
Mus musculus |
| Cell |
Stem Cell |
| Perturbation |
Tamoxifen |
| Disease |
Cell Apoptosis |
|
| 26 |
Expression data from embryonic stem cells ...
|
Mus musculus
|
Mus musculus |
| Gene |
FOXD3 |
| Cell |
Embryonic Stem Cells |
| Perturbation |
Overexpression |
| Disease |
Pluripotency and ... |
|
| 27 |
Expression data from embryonic stem cells ...
|
Mus musculus
|
Mus musculus |
| Gene |
NFATC3 |
| Cell |
Embryonic Stem Cells |
| Perturbation |
Overexpression |
| Disease |
Pluripotency and ... |
|
| 28 |
Expression data from embryonic stem cells ...
|
Mus musculus
|
Mus musculus |
| Gene |
NFATC3 |
| Cell |
Embryonic Stem Cells |
| Perturbation |
Overexpression of ... |
| Disease |
Pluripotency and ... |
|
| 29 |
Expression data from embryonic stem cells ...
|
Mus musculus
|
Mus musculus |
| Gene |
FOXD3 |
| Cell |
Embryonic Stem Cells |
| Perturbation |
Knockout |
| Disease |
Pluripotency and ... |
|
| 30 |
Expression data from embryonic stem cells ...
|
Mus musculus
|
Mus musculus |
| Gene |
FOXD3 |
| Cell |
Embryonic Stem Cells |
| Perturbation |
FOXD3 Conditional ... |
| Disease |
Pluripotency and ... |
|
| 31 |
Calcineurin-dependent transcriptome in ICN1 ...
|
Mus musculus
|
Mus musculus |
| Cell |
Lymphoblastic ... |
| Perturbation |
Tamoxifen |
| Disease |
Cancer |
|
| 32 |
Transgenic model of selective ATF6 activation: ...
|
Mus musculus
|
Mus musculus |
| Cell |
Cardiac ATF6MER ... |
| Perturbation |
Tamoxifen |
| Disease |
Endoplasmic Reticulum ... |
|
| 33 |
Transgenic model of selective ATF6 activation: ...
|
Mus musculus
|
Mus musculus |
| Cell |
Cardiac ATF6MER ... |
| Perturbation |
Tamoxifen |
| Disease |
Endoplasmic Reticulum ... |
|
| 34 |
Genes regulated by estrogen and ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 Breast Cancer |
| Perturbation |
Tamoxifen |
| Disease |
Breast Cancer` |
|
| 35 |
Expression data from chemically-induced skin ...
|
Mus musculus
|
Mus musculus |
| Gene |
SOX2 |
| Cell |
Cancer Stem Cell |
| Perturbation |
Knockin |
| Disease |
Cancer |
|
| 36 |
Expression data from adult lungs isolated from ...
|
Mus musculus
|
Mus musculus |
| Cell |
Lung |
| Perturbation |
Tamoxifen |
| Disease |
Hemorrhagic ... |
|
| 37 |
Effect of genetic Zfx deletion on gene ...
|
Mus musculus
|
Mus musculus |
| Cell |
Lymphoblastic ... |
| Perturbation |
Tamoxifen |
| Disease |
Leukemia |
|
| 38 |
Identification of Sox9-Regulated Pathways ...
|
Mus musculus
|
Mus musculus |
| Gene |
SOX9 |
| Cell |
Pancreas (Epithelial) |
| Perturbation |
Knockdown |
|
| 39 |
Murine forestomach epithelial sheets: Controls ...
|
Mus musculus
|
Mus musculus |
| Gene |
SOX9 |
| Cell |
Forestomach (Epithelial) |
| Perturbation |
Overexpression |
| Disease |
Transcriptional Profiling |
|
| 40 |
Tamoxifen effect on SRC-1-deficient ...
|
Homo sapiens
|
Homo sapiens |
| Gene |
NCOA1 |
| Cell |
Breast Cancer |
| Perturbation |
Tamoxifen |
| Disease |
Breast Cancer |
|
| 41 |
Expression data from MCF7 tumor xenografts ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Breast Cancer |
| Perturbation |
Tamoxifen |
| Disease |
Breast Cancer |
|
| 42 |
mRNA expression data from mice infected with ...
|
Mus musculus
|
Mus musculus |
| Cell |
gastric tissue |
| Perturbation |
Tamoxifen |
| Disease |
H. Pylori |
|
| 43 |
Effect of estrogen receptor- or retinoic acid ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Breast Cancer |
| Perturbation |
Tamoxifen (100nM) |
| Disease |
Breast Cancer |
|
| 44 |
Effect of estrogen receptor- or retinoic acid ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Breast Cancer |
| Perturbation |
Tamoxifen (500nM) |
| Disease |
Breast Cancer |
|
| 45 |
Tamoxifen-resistant breast cancer cell line ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 -B7 Tamoxifen ... |
| Perturbation |
Tamoxifen |
| Disease |
Breast Cancer |
|
| 46 |
Tamoxifen-resistant breast cancer cell line ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
MCF7 -G11 Tamoxifen ... |
| Perturbation |
Tamoxifen |
| Disease |
Breast Cancer |
|
| 47 |
Expression profiling in control and YY1 ...
|
Mus musculus
|
Mus musculus |
| Gene |
YY1 |
| Cell |
Intestinal Stem cell |
| Perturbation |
Tamoxifeninduced Knockout |
| Disease |
Intestinal Disease; ... |
|
| 48 |
Heart tissue from Nelf-b CreER mice
|
Mus musculus
|
Mus musculus |
| Gene |
NELF |
| Cell |
Heart Tissue |
| Perturbation |
Tamoxifeninduced Knockout |
| Disease |
Cardiac Stress |
|
| 49 |
Expression data during plantaris muscle ...
|
Mus musculus
|
Mus musculus |
| Cell |
Plantaris Muscle |
| Perturbation |
Tamoxifen |
| Disease |
Muscle Hypertrophy |
|
| 50 |
Effect of genetic Zfx deletion on gene ...
|
Mus musculus
|
Mus musculus |
| Cell |
Acute Myeloid ... |
| Perturbation |
Tamoxifen |
| Disease |
Leukemia |
|
| 51 |
Effect of genetic Zfx deletion on gene ...
|
Mus musculus
|
Mus musculus |
| Cell |
Acute Myeloid ... |
| Perturbation |
Tamoxifen |
| Disease |
Leukemia |
|
| 52 |
Estrogen receptor dynamics in diverse ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Breast Cancer |
| Perturbation |
Tamoxifen |
| Disease |
Breast Cancer |
|
| 53 |
Expression data from MCF7 wt xenografts
|
Homo sapiens
|
Homo sapiens |
| Cell |
Breast Cancer |
| Perturbation |
Tamoxifen + Gefinitinib |
| Disease |
Breast Cancer |
|
| 54 |
Comparison of Hepatocyte nuclear factor 4 ...
|
Mus musculus
|
Mus musculus |
| Cell |
Hepatocyte (HNF4alpha ... |
| Perturbation |
Tamoxifen |
| Disease |
Carcinoma |
|
| 55 |
Comparison of Hepatocyte nuclear factor 4 ...
|
Mus musculus
|
Mus musculus |
| Cell |
Hepatocyte ... |
| Perturbation |
Tamoxifen |
| Disease |
Carcinoma |
|
| 56 |
Tlx (nr2e1)-dependent gene expression in adult ...
|
Mus musculus
|
Mus musculus |
| Cell |
Neural Stem Cell |
| Perturbation |
Tamoxifen (36hr) |
| Disease |
Global Gene ... |
|
| 57 |
KMT1E Mediated H3K9 Methylation Is Required ...
|
Mus musculus
|
Mus musculus |
| Cell |
ES cells (Setdb1 ... |
| Perturbation |
Tamoxifen |
| Disease |
ES cell propagation |
|
| 58 |
Expression data from tamoxifen treated and ...
|
Mus musculus
|
Mus musculus |
| Cell |
Heart (alphaMHCMerCreMer) |
| Perturbation |
Tamoxifen (40mg/kg; 1 ... |
| Disease |
CardioMyopathy |
|
| 59 |
Expression data from tamoxifen treated and ...
|
Mus musculus
|
Mus musculus |
| Cell |
Heart (alphaMHCMerCreMer) |
| Perturbation |
Tamoxifen (40mg/kg; 4 ... |
| Disease |
CardioMyopathy |
|
| 60 |
Expression data from tamoxifen treated and ...
|
Mus musculus
|
Mus musculus |
| Cell |
Heart (Wildtype) |
| Perturbation |
Tamoxifen (40mg/kg; 4 ... |
| Disease |
CardioMyopathy |
|
| 61 |
Expression data from primary MEF lacking ...
|
Mus musculus
|
Mus musculus |
| Gene |
HDAC1 |
| Cell |
Mouse Embryonic ... |
| Perturbation |
Tamoxifen |
| Disease |
MEF transcription ... |
|
| 62 |
Expression data from primary MEF lacking ...
|
Mus musculus
|
Mus musculus |
| Gene |
HDAC1 |
| Cell |
Mouse Embryonic ... |
| Perturbation |
Tamoxifen ... |
| Disease |
MEF transcription ... |
|
| 63 |
Tlx (nr2e1)-dependent gene expression in adult ...
|
Mus musculus
|
Mus musculus |
| Cell |
Neural Stem Cell ... |
| Perturbation |
Tamoxifen (36hr) |
| Disease |
Tlx-regulated gene ... |
|
| 64 |
Tlx (nr2e1)-dependent gene expression in adult ...
|
Mus musculus
|
Mus musculus |
| Cell |
Neural Stem Cell ... |
| Perturbation |
Tamoxifen (60hr) |
| Disease |
Tlx-regulated gene ... |
|
| 65 |
Tlx (nr2e1)-dependent gene expression in adult ...
|
Mus musculus
|
Mus musculus |
| Cell |
Neural Stem Cell ... |
| Perturbation |
Tamoxifen (36hr) |
| Disease |
Tlx-regulated gene ... |
|
| 66 |
Tlx (nr2e1)-dependent gene expression in adult ...
|
Mus musculus
|
Mus musculus |
| Cell |
Neural Stem Cell ... |
| Perturbation |
Tamoxifen (60hr) |
| Disease |
Tlx-regulated gene ... |
|